Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Found 123 results
[
Author
]
Title
Type
Year
Filters:
Filter
is
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Scher JU
,
Sczesnak A
,
Longman RS
,
Segata N
,
Ubeda C
,
Bielski C
,
Rostron T
,
Cerundolo V
,
Pamer EG
,
Abramson SB
et al.
. 2013.
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.
.
Elife (Cambridge). 2:e01202.
Sandborn WJ
,
Feagan BG
,
Fedorak RN
,
Scherl E
,
Fleisher MR
,
Katz S
,
Johanns J
,
Blank M
,
Rutgeerts P
. 2008.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
.
Gastroenterology. 135(4):1130-41.
Sandborn WJ
,
Feagan BG
,
Loftus EV
,
Peyrin-Biroulet L
,
Van Assche G
,
D'Haens G
,
Schreiber S
,
Colombel J-F
,
Lewis JD
,
Ghosh S
et al.
. 2020.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
.
Gastroenterology. 158(8):2123-2138.e8.
Q
Qazi T
,
Verma R
,
Hamilton MJ
,
Kaplan ER
,
Redline S
,
Burakoff R
. 2019.
The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
.
Inflamm Bowel Dis. 25(6):1044-1053.
P
Poppers DM
,
Scherl EJ
. 2008.
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.
.
Inflamm Bowel Dis. 14(1):106-13.
Persley K
,
Scherl E
,
Rubin P
. 2001.
Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
.
Am J Gastroenterol. 96(12):3444-5.
Patel A
,
Namn Y
,
Shah SL
,
Scherl E
,
Wan DW
. 2019.
Takotsubo cardiomyopathy after an upper and lower endoscopy: a case report and review of the literature.
.
J Med Case Rep. 13(1):81.
Panaccione R
,
Danese S
,
Sandborn WJ
,
O'Brien CD
,
Zhou Y
,
Zhang H
,
Adedokun OJ
,
Tikhonov I
,
Targan S
,
Abreu MT
et al.
. 2020.
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
.
Aliment Pharmacol Ther. 52(11-12):1658-1675.
O
Otani T
,
Yamaguchi K
,
Scherl E
,
Du B
,
Tai H-H
,
Greifer M
,
Petrovic L
,
Daikoku T
,
Dey SK
,
Subbaramaiah K
et al.
. 2006.
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
.
Am J Physiol Gastrointest Liver Physiol. 290(2):G361-8.
N
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
M
Murphy SJ
,
Wang L
,
Anderson LA
,
Steinlauf A
,
Present DH
,
Mechanick JI
. 2009.
Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method.
.
Aliment Pharmacol Ther. 30(10):1078-86.
Montrose DC
,
Scherl EJ
,
Bosworth BP
,
Zhou XKathy
,
Jung B
,
Dannenberg AJ
,
Hla T
. 2013.
S1P₁ localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
.
J Lipid Res. 54(3):843-51.
Marion JF
,
Waye JD
,
Present DH
,
Israel Y
,
Bodian C
,
Harpaz N
,
Chapman M
,
Itzkowitz S
,
Steinlauf AF
,
Abreu MT
et al.
. 2008.
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
.
Am J Gastroenterol. 103(9):2342-9.
Malik F
,
Scherl E
,
Weber U
,
Carrino JA
,
Epsten M
,
Wichuk S
,
Pedersen SJ
,
Paschke J
,
Schwartzman S
,
Kroeber G
et al.
. 2021.
Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study.
.
Int J Rheum Dis.
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Ma C
,
Battat R
,
Dulai PS
,
Parker CE
,
Sandborn WJ
,
Feagan BG
,
Jairath V
. 2019.
Innovations in Oral Therapies for Inflammatory Bowel Disease.
.
Drugs. 79(12):1321-1335.
L
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Lukin DJ
,
Funez-dePagnier G
,
Lima S
,
Lai D
,
Duenas-Bianchi L
,
Ahmed W
,
Jacob V
,
Battat R
,
Scherl E
,
Longman RS
. 2021.
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
.
Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
Lukin DJ
,
Lawlor G
,
Hudesman DP
,
Durbin L
,
Axelrad JE
,
Passi M
,
Cavaliere K
,
Coburn E
,
Loftus M
,
Jen H
et al.
. 2019.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
.
Inflamm Bowel Dis. 25(4):775-781.
Lukin DJ
. 2020.
Predictors of Perianal Fistula Relapse in Crohn's Disease.
.
Inflamm Bowel Dis. 26(6):932-933.
Longman RS
,
Talal AH
,
Jacobson IM
,
Albert ML
,
Rice CM
. 2004.
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.
.
Blood. 103(3):1026-9.
Longman RS
,
Diehl GE
,
Victorio DA
,
Huh JR
,
Galan C
,
Miraldi ER
,
Swaminath A
,
Bonneau R
,
Scherl EJ
,
Littman DR
. 2014.
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
.
J Exp Med. 211(8):1571-83.
Longman RS
,
Talal AH
,
Jacobson IM
,
Rice CM
,
Albert ML
. 2005.
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.
.
J Infect Dis. 192(3):497-503.
Longman RS
,
Moreira RK
,
Littman DR
,
Green PHR
,
Sethi A
. 2012.
A rare intestinal infection with systemic effects.
.
Gastroenterol Hepatol (N Y). 8(1):60-3.
Longman RS
,
Littman DR
. 2015.
The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity.
.
Curr Opin Rheumatol. 27(4):381-7.
« first
‹ previous
1
2
(current)
3
4
5
next ›
last »